Medindia

X

China Biologic Products to Participate in the Brean Murray Carret & Co. Boston Healthcare 1x1 Conference

Thursday, February 25, 2010 General News J E 4
Advertisement

TAI'AN, China, Feb. 25 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or the "Company"), a leading plasma-based biopharmaceutical company in China, today announced that the Company's management team will attend the upcoming Brean Murray Carret & Co. ("BMC") Boston Healthcare 1x1 Conference (the "BMC 1x1 Conference"), on March 1, 2010.

The BMC 1x1 Conference venue will be The Hilton Boston Financial District, 89 Broad Street, Boston, MA 02110. China Biologic's management team will be available for one-on-one meetings with institutional investors at the conference.

Participation in the BMC Conference is by invitation only. Interested parties are asked to contact Lindsay Zuckerman at Lindsay.Zuckerman@bmur.com or call (212) 702-6577.

About China Biologic Products, Inc.

China Biologic Products, Inc. (the "Company"), through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state- owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China.

   For more information, please contact:

    Company Contact:
     Mr. Y. Tristan Kuo
     Chief Financial Officer
     China Biologic Products, Inc.
     Phone: +86-538-6202206
     Email: IR@chinabiologic.com
     Web:   http://www.chinabiologic.com

    Investor Relations Contact:
     Ms. Lei Huang, Account Manager
     CCG Investor Relations
     Phone: +1-646-833-3417
     Email: lei.huang@ccgir.com
     Web:   http://www.ccgirasia.com

     Mr. Crocker Coulson, President
     Phone: +1-646-213-1915
     Email: crocker.coulson@ccgir.com

SOURCE China Biologic Products, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
The Joan C. Edwards Charitable Foundation Makes Mu...
S
Biostar Pharmaceuticals, Inc. Provides Preliminary...